First Trust Nasdaq Lux Dgtl Hlth SoluETF (EKG)
15.97
+0.45
(+2.90%)
USD |
NASDAQ |
Apr 23, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.65% | 0.63% | 2.381M | 1440.20 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.00% | 18.00% | 1.272M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks results that correspond generally to the price and yield of an equity index called the Nasdaq Lux Health Tech Index TM (the “index”). The fund will normally invest at least 80% of its net assets (plus any borrowings for investment purposes) in the common stocks and depositary receipts that comprise the index. The index is designed to measure the performance of a selection of companies that are primarily engaged in and involved at the intersection of healthcare and technology, as classified by Lux Capital based on analysis of the products and services offered by those companies. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | First Trust Advisors L.P. |
| Prospectus Benchmark Index | |
| N_Ndaq Lux Health Tech USD_D | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Chris Peterson | 2.03 yrs |
| Daniel Lindquist | 2.03 yrs |
| David McGarel | 2.03 yrs |
| Erik Russo | 2.03 yrs |
| Jon Erickson | 2.03 yrs |
| Roger Testin | 2.03 yrs |
| Stan Ueland | 2.03 yrs |
Performance Versus Category
As of April 23, 2024. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of April 23, 2024.
Basic Info
| Investment Strategy | |
| The investment seeks results that correspond generally to the price and yield of an equity index called the Nasdaq Lux Health Tech Index TM (the “index”). The fund will normally invest at least 80% of its net assets (plus any borrowings for investment purposes) in the common stocks and depositary receipts that comprise the index. The index is designed to measure the performance of a selection of companies that are primarily engaged in and involved at the intersection of healthcare and technology, as classified by Lux Capital based on analysis of the products and services offered by those companies. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | First Trust Advisors L.P. |
| Prospectus Benchmark Index | |
| N_Ndaq Lux Health Tech USD_D | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Chris Peterson | 2.03 yrs |
| Daniel Lindquist | 2.03 yrs |
| David McGarel | 2.03 yrs |
| Erik Russo | 2.03 yrs |
| Jon Erickson | 2.03 yrs |
| Roger Testin | 2.03 yrs |
| Stan Ueland | 2.03 yrs |